Goldman Sachs upgraded Edwards Lifesciences (NYSE: EW) to Conviction Buy with a price target of $84, suggesting 23% upside.

This article: 115 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE